TY - JOUR
T1 - Cytokine exposure mediates transcriptional activation of the orphan nuclear receptor Nur77 in hematopoietic cells
AU - Martino, Orsola di
AU - Niu, Haixia
AU - Hadwiger, Gayla
AU - Ferris, Margaret A.
AU - Welch, John S.
N1 - Funding Information:
We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, MO. for the use of the Flow Cytometry Core, the High-Throughput Screening Center, and the Proteomics Core. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant P30 CA91842. We thank Deborah Laflamme, Conner York, Sangeetha Vadivelu, Anh Vu, and Maxene Ilagan for technical assistance. The expert technical assistance of Petra Erdmann-Gilmore, Jim Malone, Dr Yiling Mi, and Rose Connors (Proteomics Core) is gratefully acknowledged. The WU-PSR is supported in part by the WU Institute of Clinical and Translational Sciences (NCATS UL1 TR000448), the Mass Spectrometry Research Resource (NIGMS P41 GM103422; R24GM136766) and the Siteman Comprehensive Cancer Center Support Grant (NCI P30 CA091842).
Funding Information:
Funding and additional information—This work was supported by NIH R01 HL128447 (J. S. W.), the Children’s Discovery Institute (J. S. W.), the Alex’s Lemonade Stand Foundation Young Investigator Award (M. A. F.), and the National Institutes of Health 5K12HD07622408 (M. A. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
Acknowledgments—We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St Louis, MO. for the use of the Flow Cytometry Core, the High-Throughput Screening Center, and the Proteomics Core. The Siteman Cancer Center is supported in part by an NCI Cancer Center Support Grant P30 CA91842. We thank Deborah Laflamme, Conner York, Sangeetha Vadivelu, Anh Vu, and Maxene Ilagan for technical assistance. The expert technical assistance of Petra Erdmann-Gilmore, Jim Malone, Dr Yiling Mi, and Rose Connors (Proteomics Core) is gratefully acknowledged. The WU-PSR is supported in part by the WU Institute of Clinical and Translational Sciences (NCATS UL1 TR000448), the Mass Spectrometry Research Resource (NIGMS P41 GM103422; R24GM136766) and the Siteman Comprehensive Cancer Center Support Grant (NCI P30 CA091842).
Publisher Copyright:
© 2021 THE AUTHORS
PY - 2021/11/1
Y1 - 2021/11/1
N2 - The orphan nuclear receptor Nur77 is an immediate-early response gene that based on tissue and cell context is implicated in a plethora of cellular processes, including proliferation, differentiation, apoptosis, metabolism, and inflammation. Nur77 has a ligand-binding pocket that is obstructed by hydrophobic side groups. Naturally occurring, cell-endogenous ligands have not been identified, and Nur77 transcriptional activity is thought to be regulated through posttranslational modification and modulation of protein levels. To determine whether Nur77 is transcriptionally active in hematopoietic cells in vivo, we used an upstream activating sequence (UAS)-GFP transgenic reporter. We found that Nur77 is transcriptionally inactive in vivo in hematopoietic cells under basal conditions, but that activation occurs following cytokine exposure by G-CSF or IL-3. We also identified a series of serine residues required for cytokine-dependent transactivation of Nur77. Moreover, a kinase inhibitor library screen and proximity labeling-based mass spectrometry identified overlapping kinase pathways that physically interacted with Nur77 and whose inhibition abrogated cytokine-induced activation of Nur77. We determined that transcriptional activation of Nur77 by G-CSF or IL-3 requires functional JAK and mTor signaling since their inhibition leads to Nur77 transcriptional inactivation. Thus, intracellular cytokine signaling networks appear to regulate Nur77 transcriptional activity in mouse hematopoietic cells.
AB - The orphan nuclear receptor Nur77 is an immediate-early response gene that based on tissue and cell context is implicated in a plethora of cellular processes, including proliferation, differentiation, apoptosis, metabolism, and inflammation. Nur77 has a ligand-binding pocket that is obstructed by hydrophobic side groups. Naturally occurring, cell-endogenous ligands have not been identified, and Nur77 transcriptional activity is thought to be regulated through posttranslational modification and modulation of protein levels. To determine whether Nur77 is transcriptionally active in hematopoietic cells in vivo, we used an upstream activating sequence (UAS)-GFP transgenic reporter. We found that Nur77 is transcriptionally inactive in vivo in hematopoietic cells under basal conditions, but that activation occurs following cytokine exposure by G-CSF or IL-3. We also identified a series of serine residues required for cytokine-dependent transactivation of Nur77. Moreover, a kinase inhibitor library screen and proximity labeling-based mass spectrometry identified overlapping kinase pathways that physically interacted with Nur77 and whose inhibition abrogated cytokine-induced activation of Nur77. We determined that transcriptional activation of Nur77 by G-CSF or IL-3 requires functional JAK and mTor signaling since their inhibition leads to Nur77 transcriptional inactivation. Thus, intracellular cytokine signaling networks appear to regulate Nur77 transcriptional activity in mouse hematopoietic cells.
UR - http://www.scopus.com/inward/record.url?scp=85118937628&partnerID=8YFLogxK
U2 - 10.1016/j.jbc.2021.101240
DO - 10.1016/j.jbc.2021.101240
M3 - Article
C2 - 34571009
AN - SCOPUS:85118937628
SN - 0021-9258
VL - 297
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 5
M1 - 101240
ER -